BLOG.FRANKMS.COM: Category Archive for MS Pharma

FDA Warning

Posted by Frank at 5/17/2012 7:07 PM | Add Comment

American Association of Neurology Abstract Presentation

Posted by Frank at 4/24/2012 6:35 PM | Add Comment

Watchdog Group Wants Restrictions on Fingolimod for MS

Posted by Frank at 4/10/2012 1:24 PM | Add Comment

Fast Forward LLC,

Posted by Frank at 3/5/2012 12:16 PM | Add Comment

ASCEND SP MS TRIAL

Posted by Frank at 1/26/2012 7:16 PM | Add Comment

Google MS Search 1/21

Posted by Frank at 1/24/2012 9:46 AM | Add Comment

Per Morgan Stanley; Teva raised the price of Copaxone 14.9% yesterday, January 3, 2012

Posted by Frank at 1/4/2012 10:55 AM | Add Comment

Tovaxin® (T cell vaccination) granted fast-track designation by FDA

Posted by Frank at 12/15/2011 8:37 AM | Add Comment

Analysis: Why in an age of health cuts we need more government research

Posted by Frank at 8/4/2011 5:50 PM | Add Comment

MS Trial Alert: Recruiting for a Nationwide Study of an Investigational New Treatment for Spasticity

Posted by Frank at 7/25/2011 8:16 AM | Add Comment

Benefit of Disease-Modifying MS Drugs Comes at High Cost

Posted by Frank at 7/22/2011 10:24 PM | Add Comment

Excerpt from a Letter to the Editor!

Posted by Frank at 6/26/2011 5:17 PM | Add Comment

Supreme Court Strikes Down Ban on Data-Mining

Posted by Frank at 6/23/2011 11:48 AM | Add Comment

MS Drug Prices

Posted by Frank at 6/11/2011 10:02 AM | Add Comment

Viagra reverses nerve disease:

Posted by Frank at 5/23/2011 12:56 PM | Add Comment

Novartis’s $48,000 Pill Spurs U.S. Price Increases for MS Drugs

Posted by Frank at 5/22/2011 4:04 PM | Add Comment

Cardiovascular Risks With Oral Fingolimod for Multiple Sclerosis

Posted by Frank at 4/25/2011 8:44 AM | Add Comment

Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial.

Posted by Frank at 4/18/2011 11:14 AM | Add Comment

Drug costs in Upstate NY

Posted by Frank at 3/9/2011 2:15 PM | Add Comment

5 New Cases of PML

Posted by Frank at 11/21/2010 5:03 PM | Add Comment

FDA warns of brain risk with frequent Tysabri use

Posted by Frank at 2/5/2010 2:25 PM | Add Comment

Discontinuing disease-modifying therapy in progressive multiple sclerosis: can we stop what we have started?

Posted by Frank at 1/2/2010 5:56 PM | Add Comment